The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Open accessAbstract
Cytokine storm syndrome has generally been described as a collection of clinical manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are associated with various pathologies, as observed in infectious diseases, certain acquired or inherited immunodeficiencies and autoinflammatory diseases, or following therapeutic interventions. Despite the role of CS in tissue damage and multiorgan failure, a systematic understanding of its underlying molecular mechanisms is lacking. Recent studies demonstrate a positive feedback loop between cytokine release and cell death pathways; certain cytokines, PAMPs, and DAMPs, can activate inflammatory cell death, leading to further cytokine secretion. Here, we discuss recent progress in innate immunity and inflammatory cell death, providing insights into the cellular and molecular mechanisms of CSs and therapeutics that might quell ensuing life-threatening effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice
Sharma, B. R., Karki, R., Lee, E., Zhu, Q., Gurung, P., & Kanneganti, T. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0159-7 · Cited by 33
Self-citationDistinct role of IL-1β in instigating disease in Sharpincpdm mice
Gurung, P., Sharma, B. R., & Kanneganti, T. (2016) · Scientific Reports · doi:10.1038/srep36634 · Cited by 31
Self-citationJiang, X., Tian, H., Fan, Y., Chen, J., Song, Y., Wang, S., Zhu, F., Guo, C. H., Zhang, L., & Shi, Y. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00500-12 · Cited by 26
Gatza, E., Braun, T., Levine, J. E., Ferrara, J. L. M., Zhao, S. G., Wang, T., Chang, L., Harris, A. C., Pawarode, A., Kitko, C. L., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.05.023 · Cited by 24
Kumar, A., & Kato, H. (2016) · Case Reports in Rheumatology · doi:10.1155/2016/3717392 · Cited by 20
Kelly, C., Williams, M. T. S., Elborn, J. S., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.009 · Cited by 16
Letter: immunotherapy in IBD patients in a SARS‐CoV‐2 endemic area
Waggershauser, C. H., Tillack‐Schreiber, C., Berchthold-Benchieb, C., Szokodi, D., Howaldt, S. M., & Ochsenkühn, T. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15897 · Cited by 12
Cited by
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Self-citationAcute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 615
Wang, Y., & Kanneganti, T.-D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.038 · Cited by 545
Self-citationKarki, R., Lee, S., Mall, R., Pandian, N., Wang, Y., Sharma, B. R., Malireddi, R. S., Yang, D., Trifkovic, S., Steele, J. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo6294 · Cited by 350
Self-citationProgrammed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
Metadata
- Authors
- Karki, R., & Kanneganti, T.-D.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 42
- Issue
- 8
- Pages
- 681-705
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W3174877434
- Cited by
- 438
- References
- 207
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.